SCHEMBL14440206

SCHEMBL14440206

C=C1[C@H](n2cnc3c(Cl)ncnc32)O[C@H](COCCCC)[C@@H](OCCCC)[C@H](OCCCC)[C@H]1OCCCC

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TYMP P19971 1/20 0.36
▸ AHCY P23526 1/20 0.35
▸ ADORA3 P0DMS8 4/20 0.34
▸ EHMT1 Q9H9B1 1/20 0.34
▸ SLC29A1 Q99808 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ADK P55263 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ P2RX3 P56373 1/20 0.31
▸ P2RX2 Q9UBL9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14440925 0.84 TYMP (0.42) TYMPAHCYADORA3EHMT1SLC29A1
SCHEMBL14440555 0.81 HIF1A (0.39) TYMPAHCYADORA3EHMT1
SCHEMBL14440608 0.81 HIF1A (0.39) TYMPAHCYADORA3EHMT1
SCHEMBL14440209 0.81 TYMP (0.50) TYMPAHCYADORA3EHMT1SLC29A1
SCHEMBL14568433 0.81 HIF1A (0.39) TYMPAHCYADORA3EHMT1
SCHEMBL14440609 0.81 HIF1A (0.39) TYMPAHCYADORA3EHMT1
SCHEMBL14440197 0.81 HIF1A (0.39) TYMPAHCYADORA3EHMT1
SCHEMBL14440950 0.81 HIF1A (0.39) TYMPAHCYADORA3EHMT1
SCHEMBL14429164 0.80 PDE2A (0.47) TYMPAHCYSLC29A1ADORA2AADORA1
SCHEMBL14440203 0.80 TYMP (0.43) TYMPAHCYADORA3EHMT1SLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185063-A1 Seven-membered ring nucleosides IDENIX PHARMACEUTICALS, INC. 2007-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185063-A1 Seven-membered ring nucleosides NSUN2, NSUN3, HAVCR2 TYMP 148/4885AHCY 531/4885ADORA3 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback